Health Catalyst (HCAT) Cash & Current Investments (2018 - 2026)

Health Catalyst's Cash & Current Investments history runs 9 years deep, the most recent figure standing at $108.8 million for Q1 2026.

• Quarterly Cash & Current Investments fell 68.18% year-over-year to $108.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108.8 million (down 68.18% YoY) and the FY2025 annual result came in at $95.7 million, down 75.58% from the prior year.
• Cash & Current Investments was $108.8 million for Q1 2026 at Health Catalyst, up from $95.7 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $425.4 million in Q1 2022 and bottomed at $91.5 million in Q3 2025.
• A 5-year average of $299.4 million and a median of $343.8 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 59.67% — and 2025, when it plunged 76.36%.
• Health Catalyst's Cash & Current Investments stood at $363.5 million in 2022, then decreased by 12.59% to $317.7 million in 2023, then grew by 23.38% to $392.0 million in 2024, then sank by 75.58% to $95.7 million in 2025, then grew by 13.67% to $108.8 million in 2026.
• Business Quant data shows HCAT's Cash & Current Investments at $108.8 million in Q1 2026, $95.7 million in Q4 2025, and $91.5 million in Q3 2025.